Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

5.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.5K
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

711
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
711
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

598
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
598
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.7K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

1.2K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply from Y. Lu, C. A. Whiteis, K. A. Sluka, M. W. Chapleau and F. M. Abboud.

The Journal of physiology·2013
Same author

Dual mechanisms of angiotensin-induced activation of mouse sympathetic neurones.

The Journal of physiology·2006
Same author

Slow inactivation of sodium currents in the rat nodose neurons.

Autonomic neuroscience : basic & clinical·2001
Same author

Mechanisms determining sensitivity of baroreceptor afferents in health and disease.

Annals of the New York Academy of Sciences·2001
Same author

ENaC subunits are molecular components of the arterial baroreceptor complex.

Annals of the New York Academy of Sciences·2001
Same author

Neuro-cardiovascular regulation: from molecules to man. Introduction.

Annals of the New York Academy of Sciences·2001

Related Experiment Video

Updated: May 5, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

15.2K

Hemodynamic effects of ventricular defibrillation.

D G Pansegrau, F M Abboud

    The Journal of Clinical Investigation
    |February 1, 1970
    PubMed
    Summary

    Ventricular defibrillation triggers distinct cholinergic and adrenergic responses in dogs. The cholinergic response can be detrimental, while the adrenergic response is crucial for successful defibrillation.

    Area of Science:

    • Cardiovascular Physiology
    • Autonomic Nervous System
    • Electrophysiology

    Background:

    • Ventricular fibrillation (VF) is a life-threatening arrhythmia requiring electrical defibrillation.
    • Hemodynamic consequences of defibrillation are not fully understood.
    • Understanding these responses is critical for optimizing resuscitation protocols.

    Purpose of the Study:

    • To investigate the hemodynamic and autonomic responses to ventricular defibrillation in anesthetized dogs.
    • To differentiate the effects of VF conversion from the electrical shock itself.
    • To elucidate the roles of cholinergic and adrenergic systems in defibrillation outcomes.

    Main Methods:

    • Induction and termination of ventricular fibrillation using electrical stimuli in dogs.

    More Related Videos

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
    05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    7.7K
    A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
    07:56

    A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

    Published on: February 17, 2023

    1.4K

    Related Experiment Videos

    Last Updated: May 5, 2026

    A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
    09:47

    A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

    Published on: April 26, 2015

    15.2K
    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
    05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    7.7K
    A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
    07:56

    A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

    Published on: February 17, 2023

    1.4K
  • Continuous monitoring of hemodynamic parameters: arterial pressure, atrial pressures, cardiac output, heart rate.
  • Pharmacological interventions (vagotomy, atropine, propranolol, phenoxybenzamine) to assess autonomic components.

    • Main Results:

    • Defibrillation elicited biphasic hemodynamic responses: an early cholinergic phase (bradycardia, arrhythmias) and a later adrenergic phase (increased arterial pressure, cardiac output).
    • Cholinergic effects were blocked by vagotomy and atropine; adrenergic effects were blocked by propranolol and phenoxybenzamine.
    • Responses were primarily due to VF conversion, not the shock itself, and intensified with longer VF duration.
    • Depletion of catecholamines impaired survival after defibrillation.

    Conclusions:

    • The cholinergic component of the defibrillation response may promote VF recurrence and is potentially detrimental.
    • The adrenergic component is essential for successful defibrillation, highlighting the importance of endogenous catecholamines.
    • These findings provide insights into the complex physiological adjustments following electrical cardioversion of VF.